Latest Lung Cancer Related News
Lung Cancer News From Medical News Today
- Gene Panel Predicts Lung Cancer Survival
Tuesday July 22, 2008 Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. The study, the largest of its kind, appears online in Nature Medicine.
- BioNumerik Pharmaceuticals Observes Evidence Of A Survival Increase In Lung Cancer Patients Participating In Tavocept(TM) Clinical Trial
Friday July 18, 2008 BioNumerik Pharmaceuticals, Inc. ("BioNumerik") announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept.
- Anti-Tobacco Campaign Tests Lung Capacity, Determination And Tobacco Awareness In 'Miley Mania Adventure'
Thursday July 10, 2008 Pop culture, anti-tobacco awareness and physical endurance merged last Friday in The TRUTH's 'Miley Mania Adventure' in Salt Lake City. Twenty parent-child teams faced six anti-tobacco riddles that lead them to scavenge over 50 miles of the Wasatch Front with nothing more than their own two feet and the local public transit system.
- Greater Gains In Mortality Reduction From Common Cancers Associated With Higher Education
Wednesday July 9, 2008 Deaths due to the four most common cancers - lung, colorectal, prostate, and breast - have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains.
- Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine Or Vinorelbine In Performance Status (PS 2) NSCLC Patients
Monday July 7, 2008 Cell Therapeutics, Inc. (CTI) announced the publication of results from its randomized phase III trial comparing OPAXIO(TM) (paclitaxel poliglumex, CT-2103) with gemcitabine or vinorelbine for the treatment of PS 2 (performance status 2) patients with previously untreated non-small cell lung cancer (NSCLC) in the Journal of Thoracic Oncology (Volume 3, Number 7, July 2008). Results showed that overall survival was similar between the two arms (hazard ratio of 0.
- A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment
Friday July 4, 2008 Research and Markets has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering.
- Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers
Thursday July 3, 2008 Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.
- Linking Second-Hand Smoke And Lung Cancer
Thursday July 3, 2008 It is a widely accepted notion that second-hand smoke (SHS) is linked to lung cancer. However, medical professionals and researchers have not reached consensus on the extent of the increase in cancer risk due to SHS.
- Smokeless Tobacco Can Also Increase Cancer Risk
Thursday July 3, 2008 A review published in The Lancet Oncology finds that although users of smokeless tobacco products (STPs) likely have a lower cancer risk than smokers, they are still increasing their risk of developing several types of cancer. In the USA and Sweden, a finely cut or powered, flavored tobacco called moist snuff is the most popular form of STP used. In places like India, there is a wide range of products that are regularly consumed.
- Smoke-Free Policies Are Achieving Intended Goals
Wednesday July 2, 2008 A new article published in The Lancet Oncology claims that the recent smoke-free policy initiatives have resulted in numerous public health gains. The special report from the International Agency for Cancer Research (IARC) reveals that the policies have been instrumental in reducing heart disease related to smoke exposure, diminishing the number of adults who smoke, and curbing second-hand smoke exposure to adults and children.
- Percutaneous Radiofrequency Ablation Shows Promise In The Treatment Of Lung Tumours
Tuesday July 1, 2008 Percutaneous radiofrequency ablation - a minimally invasive treatment technique that heats and destroys cancer cells - achieves a high rate of sustained complete responses in selected patients with lung tumours, according to results from the first prospective study of patients treated with technique. Tumours in the lungs are common. Lung cancer is the leading cause of cancer death in both men and women.
- Peregrine Pharmaceuticals Doses First Patient In Phase II Trial Of Bavituximab In Patients With Non-Small Cell Lung Cancer
Tuesday July 1, 2008 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC). The primary objective of the study is to assess the overall response rate to the combination of bavituximab with a standard regimen of carboplatin and paclitaxel in NSCLC patients.
- Faulty DNA Repair May Increase Lung Cancer Risk In Nonsmokers
Friday June 27, 2008 People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center. "About 15 percent of lung cancers occur in lifetime never smokers.
- New Clinical Trial For Patients With Asbestos-Associated Lung Cancer
Friday June 27, 2008 The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.
- Scientists From The University Of Navarra Find 5 Genes Involved In The Metastasis Of Breast Tumours To The Lung
Saturday June 21, 2008 The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra, the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra. Doctor Alfonso Calvo, researcher in the area of Oncology at the CIMA, led the work with the special collaboration of Doctor Ignacio Gil Bazo, cancer specialist from the University Hospital.
- CB1400, Patented By Canopus BioPharma, Prevents Tumor Growth And Enhances The Anti-Tumor Effects Of Cisplatin And Cetuximab (Erbitux)
Friday June 20, 2008 Canopus BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and has also demonstrated the synergistic effect of this drug in combination with both cisplatin and cetuximab (Erbitux) in two mice lung cancer models. Chairman of Canopus BioPharma, Dr.
- Researchers Optimistic About New Therapy For Lung Cancer
Friday June 20, 2008 An article in the July edition of The Lancet Oncology suggests that a common treatment for liver cancer - radiofrequency ablation - can also be used to treat lung cancer. A team of European and American researchers calls for randomized controlled trials in order to more robustly investigate this minimally invasive procedure for cancer treatment. In both men and women, lung cancer causes the most cancer deaths, and 80% of these are non-small-cell lung cancer (NSCLC).
- Can A Natural Vitamin Help Slow Lung Cancer? Study Looks At Role Vitamin D May Play In Shielding Lungs From Tumors
Wednesday June 18, 2008 You can get Vitamin D from the sunlight on a warm sunny day, from drinking a cool glass of milk or from supplements at the store, but no matter how you get it, a healthy dose of Vitamin D may be doing more good than first thought. In the laboratory, scientists have discovered that high doses of this common vitamin may help slow or prevent the growth of cancer cells. Building miniature ships is a tedious hobby, but David Rose doesn't mind.
- Hi-Tech Radiation Zaps "Moving Targets" On Lungs - Powerful Radiation Therapy Yields Remarkable Results In Lung Cancers
Wednesday June 18, 2008 It might surprise you to know that lung cancer claims more lives than breast, colon, and prostate cancers combined. Part of the problem is that lung cancer is often diagnosed late, so there aren't as many treatment options for patients. Now, that may be changing. Doctors are now using powerful radiation beams to zap lung tumors and give patients new hope. Arthur Koscielnaik knows how lucky he is to be able to share special moments with his children.
- EMEA Recommends Information On Lung Cancer Cases To Be Included In Exubera Product Information, Europe
Wednesday June 18, 2008 The European Medicines Agency (EMEA) has recommended that the product information for Exubera be updated with new information on cases of lung cancer seen in patients taking the medicine. Exubera, from Pfizer Limited, is a fast-acting insulin powder for inhalation, used for the treatment of adults with type 1 or type 2 diabetes.
- For Smokers, Lung Cancer Risk Not Greater For Women
Saturday June 14, 2008 A paper published in The Lancet Oncology has concluded that women smokers are not at a greater risk of developing lung cancer than male smokers. However, among those who have never smoked, women appear to be more likely to develop the disease than men. In the United States, the medical and health community mostly agrees that cigarette smoking is responsible for about 90% of lung cancers.
- Five-Year Project Will Examine Health Effects Of Exposure To Libby Amphibole Asbestos
Thursday June 12, 2008 The U.S. Department of Health and Human Services (HHS) and the U.S. Environmental Protection Agency (EPA) announced the Libby Amphibole Health Risk Initiative, a series of projects totaling $8 million designed to understand the health effects of exposure to lower levels of Libby, Montana asbestos (i.e., Libby amphibole).
- CT Lung Cancer Screening No Cure-All For Smokers
Thursday June 12, 2008 Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current and former smokers, but it won't protect them from other causes of death associated with smoking, according to a new study published in the July issue of the journal Radiology. "Our study suggests that screening may be one way to reduce risk of death from lung cancer," said the study's lead author, Pamela McMahon, Ph.D.
- Rosetta Genomics And M. D. Anderson To Develop A MicroRN Based Diagnostic Test To Identify Risk Of Recurrence Of Lung Cancer
Saturday June 7, 2008 Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced a research collaboration with The University of Texas M. D. Anderson Cancer Center and the Kleberg Center for Molecular Markers to develop a microRNA- based diagnostic test to predict risk of disease recurrence in lung cancer patients who have undergone curative resection.
- One Step Closer To Tailored Treatment For Lung Cancer
Friday June 6, 2008 A major study released in the Journal of Clinical Oncology has shown that doctors could increase the survival of patients with a specific type of lung cancer to over 12 months, if they match choice of chemotherapy with the type of tissue in a patient's tumour. Mick Peake, Lung Cancer Specialist and Chair of the Clinical Reference Group for the UK Lung Cancer Coalition (UKLCC) commented, "This is a very important opportunity to re-assess how we treat people with NSCLC.
Lung Cancer - Overview
Lung Cancer is a type of cancer that forms in tissues of the lung, usually in the cells lining air passages. Many lung cancers begin in the bronchi though others can start in other parts of the lungs. Lung cancer also has a tendency to form in the glands below the bronchi.
Lung Cancer - Probabilities
Lung cancer causes up to 30% of all cancer related deaths, and it is the 2nd leading cause of death among both men and women in western society. 85% of all lung cancers are caused by a person's smoking habit or just by breathing in the second-hand smoke of others.
Lung Cancer - Screening
At this moment in time, there is no particularly useful single test that can be considered 100% reliable for the early detection of lung cancer. Unfortunately unless someone is undergoing a health screen for something completely unrelated, lung cancer is very often only discovered in the later stages of the disease when it is often too late to do anything but offer palliative treatment.
Lung Cancer - Symptoms
The most common indicators and symptoms of lung cancer include the following: Fatigue Shortness of breath and wheezing (dyspnoea) A cough that doesn't go away and gets worse over time Repeated problems with pneumonia or bronchitis Constant chest pain Coughing up blood (bloody sputum) (haemoptysis) Swelling of the neck and face Fever Loss of appetite and Weight loss (anorexia) Hoarse voice
Lung Cancer Treatment Options - Radiation
In many cases of lung cancer, surgery is not an option. This may be because of the advanced stage of the cancer, the location of the tumor or tumors, or because of the overall general health of the patient. In those cases, the oncologist may suggest radiation therapy to treat lung cancer. Even if surgery is an option, the doctor may suggest irradiation either before therapy to shrink the tumor or after surgery to destroy any remaining cancer cells.
Lung Cancer - Trends by Ethnicity, Sex and Race
In the USA and many other western countries, lung cancer is the leading cause of cancer death. Lung cancer has been found to be the leading cancer killer among Caucasians, African-Americans, Asians and Hispanic males.